Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest Expenses (2016 - 2018)

Lisata Therapeutics' Interest Expenses history spans 9 years, with the latest figure at $2000.0 for Q2 2018.

  • For Q2 2018, Interest Expenses fell 99.02% year-over-year to $2000.0; the TTM value through Mar 2019 reached $2000.0, down 99.1%, while the annual FY2018 figure was $5000.0, 98.68% down from the prior year.
  • Interest Expenses reached $2000.0 in Q2 2018 per LSTA's latest filing, down from $3000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $926817.0 in Q1 2016 to a low of $2000.0 in Q2 2018.
  • Average Interest Expenses over 5 years is $282024.4, with a median of $193980.5 recorded in 2014.
  • Peak YoY movement for Interest Expenses: surged 485.16% in 2015, then tumbled 99.02% in 2018.
  • A 5-year view of Interest Expenses shows it stood at $372158.0 in 2014, then rose by 28.23% to $477220.0 in 2015, then plummeted by 62.65% to $178236.0 in 2016, then plummeted by 96.69% to $5901.0 in 2017, then crashed by 66.11% to $2000.0 in 2018.
  • Per Business Quant, the three most recent readings for LSTA's Interest Expenses are $2000.0 (Q2 2018), $3000.0 (Q1 2018), and $5901.0 (Q4 2017).